Photoexcitation of tumor-targeted corroles induces singlet oxygen-mediated augmentation of cytotoxicity

The tumor-targeted corrole particle, HerGa, displays preferential toxicity to tumors in vivo and can be tracked via fluorescence for simultaneous detection, imaging, and treatment. We have recently uncovered an additional feature of HerGa in that its cytotoxicity is enhanced by light irradiation. In...

Full description

Saved in:
Bibliographic Details
Published inJournal of controlled release Vol. 163; no. 3; pp. 368 - 373
Main Authors Hwang, Jae Youn, Lubow, David J., Chu, David, Sims, Jessica, Alonso-Valenteen, Felix, Gray, Harry B., Gross, Zeev, Farkas, Daniel L., Medina-Kauwe, Lali K.
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier B.V 10.11.2012
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The tumor-targeted corrole particle, HerGa, displays preferential toxicity to tumors in vivo and can be tracked via fluorescence for simultaneous detection, imaging, and treatment. We have recently uncovered an additional feature of HerGa in that its cytotoxicity is enhanced by light irradiation. In the present study, we have elucidated the cellular mechanisms for HerGa photoexcitation-mediated cell damage using fluorescence optical imaging. In particular, we found that light irradiation of HerGa produces singlet oxygen, causing mitochondrial damage and cytochrome c release, thus promoting apoptotic cell death. An understanding of the mechanisms of cell death induced by HerGa, particularly under conditions of light-mediated excitation, may direct future efforts in further customizing this nanoparticle for additional therapeutic applications and enhanced potency. [Display omitted]
Bibliography:http://dx.doi.org/10.1016/j.jconrel.2012.09.015
David J. Lubow
Department of Biomedical Sciences, Cedars-Sinai Medical Center Address: 8700 Beverly Blvd. D3059, Los Angeles, CA 90048 Tel: (+1) 310-423-7377, Fax: (+1) 310-423-7707, david.lubow@cshs.org
Department of Chemistry and the Beckman Institute, California Institute of Technology Address: Beckman Institute, California Institute of Technology, Pasadena, CA 91125 Tel: (+1) 626-395-6500, Fax: (+1) 626-449-4159, hbgray@caltech.edu
Daniel L. Farkas, Ph. D.
Department of Biomedical Sciences, Cedars-Sinai Medical Center Address: 8700 Beverly Blvd. D3059, Los Angeles, CA 90048 Tel: (+1) 310-423-7377, Fax: (+1) 310-423-7707, david.chu@cshs.org
Harry B. Gray, Ph. D.
Department of Biomedical Engineering, University of Southern California The Beckman Institute, California Institute of Technology, Current address: Spectral Molecular Imaging, Inc., 250 N. Robertson Blvd., Suite 427, Beverly Hills, CA 90211, Tel: (+1) 310-858-1670, Fax: (+1) 310-858-1699, dlfarkas@gmail.com
Department of Biomedical Sciences, Cedars-Sinai Medical Center Address: 8700 Beverly Blvd. D3059, Los Angeles, CA 90048 Tel: (+1) 310-423-7377, Fax: (+1) 310-423-7707, Jessica.Sims@cshs.org
Felix Alonso-Valenteen
Department of Biomedical Engineering, University of Southern California Minimally Invasive Surgical Technologies Institute, Departments of Surgery, and Department of Biomedical Sciences, Cedars-Sinai Medical Center, Address: 1042 Downey Way, DRB 126, Los Angeles, CA 90089, Tel: (+1) 213-821-2648, Fax: (+1) 310-423-7707, jaeyhwan@usc.edu
Department of Biomedical Sciences, Cedars-Sinai Medical Center Address: 8700 Beverly Blvd. D3059, Los Angeles, CA 90048 Tel: (+1) 310-423-7377, Fax: (+1) 310-423-7707, Felix.Alonso-Valenteen@cshs.org
Jae Youn Hwang, Ph. D.
Jessica Sims
Zeev Gross, Ph. D.
David Chu
Schulich Faculty of Chemistry, Technion-Israel Institute of Technology Address: Technion-Israel Institute of Technology, Haifa 32000, Israel Tel: (+972) 4-8293954, Fax: (+972) 4-8295703, chr10zg@tx.technion.ac.il
ISSN:0168-3659
1873-4995
DOI:10.1016/j.jconrel.2012.09.015